Alzheimer’s drug donanemab: what promising trial means for treatments

被引：0

作者：

Sara Reardon

机构：

来源：

Nature | 2023年 / 617卷

关键词：

Brain; Drug discovery; Alzheimer's disease;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Results suggest that the amyloid-targeting drug candidate slows cognitive decline in some people, but questions remain over its potential side effects.

引用

页码：232 / 233

页数：1